Literature DB >> 4072781

The pathogenetic and prognostic significance of blood-brain barrier damage at the acute stage of aneurysmal subarachnoid haemorrhage. Clinical and experimental studies.

T Dóczi.   

Abstract

In a retrospective study, pathological tissue enhancement was found in nearly two fifths of patients with acute SAH on contrast-enhanced cranial computed tomography. By means of absorption measurements with the region of interest technique over the basal ganglia, it was proved indirectly that pathological tissue enhancement should be brought about not only by hyperaemia, i.e., a blood volume increase, but also by extravasation of the contrast material, i.e., blood-brain barrier (BBB) disruption. A similar conclusion was drawn from the retrospective isotope brain scintigraphy study. It was further established that, although the pathological contrast enhancement was most obvious in the cortex, and particularly in the neighbourhood of the subarachnoid spaces, the phenomenon is probably widespread throughout the brain. Patients with abnormal enhancement are likely to be in less favourable clinical grades, have a high incidence of marked or diffuse spasm, have a poorer outcome independent of surgical or conservative treatment, and develop cerebral infarction more frequently. Systemic arterial hypertension was associated with an increased incidence of abnormal enhancement. Pathological tissue contrast enhancement or isotope accumulation in the first few days of SAH may serve as prognostic signs indicative of the late development of vasospasm and ischaemia. As ischaemic disruption of the capillary system is not prominent in the initial days following any stroke, vasoactive substances arising from the breakdown of the blood clot should play important part in the BBB damage in the acute stage of SAH. The "cortical SAH" model developed in the animal experiments ensured a constant subarachnoid blood volume with minimal local brain damage. The intracranial pressure and mean arterial blood pressure did not change significantly, and perfusion defects did not arise. Thus, this model proved suitable for studying the influence on the BBB of vasoactive blood breakdown products (responsible for arterial spasm) without the accompanying effects of pathological conditions such as raised intracranial pressure, systemic hypertension, non-reflow phenomena, which also disrupt the BBB. Measurements on the water, electrolyte, albumin contents of brain tissue, as well as the immunohistochemical localization of albumin, clearly indicated that the brain oedema developing at the acute stage of experimental SAH could be classified as having a primary vasogenic component in addition to the cytotoxic component. This increased capillary permeability was found to be brought about by opening of tight junctions and pinocytosis in the endothelial cells. The pathological capillary permeabilit

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4072781     DOI: 10.1007/BF01476215

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  62 in total

1.  An extravascular component of contrast enhancement in cranial computed tomography. Part I. The tissue-blood ratio of contrast enhancement.

Authors:  M H Gado; M E Phelps; R E Coleman
Journal:  Radiology       Date:  1975-12       Impact factor: 11.105

2.  Computerized x-ray scanning of the brain.

Authors:  J Ambrose
Journal:  J Neurosurg       Date:  1974-06       Impact factor: 5.115

3.  Surgical risk as related to time of intervention in the repair of intracranial aneurysms.

Authors:  W E Hunt; R M Hess
Journal:  J Neurosurg       Date:  1968-01       Impact factor: 5.115

4.  Effect of an acute increase of the intravascular pressure on the blood-brain barrier: a comparison between conscious and anesthetized rats.

Authors:  B B Johansson
Journal:  Stroke       Date:  1978 Nov-Dec       Impact factor: 7.914

5.  Cerebral arterial blood flow and aneurysm surgery. Part 2: Induced hypotension and autoregulatory capacity.

Authors:  H Nornes; H B Knutzen; P Wikeby
Journal:  J Neurosurg       Date:  1977-12       Impact factor: 5.115

6.  [Quantitative determination of the permeability of the so-called blood-brain barrier of Evans blue (T 1824)].

Authors:  W Rössner; K Tempel
Journal:  Med Pharmacol Exp Int J Exp Med       Date:  1966

7.  Responses of isolated human basilar arteries to 5-hydroxytryptamine, noradrenaline, serum, platelets, and erythrocytes.

Authors:  L M Starling; D J Boullin; D G Grahame-Smith; C B Adams; R S Gye
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-07       Impact factor: 10.154

8.  Pathogenetic role of no-reflow phenomenon in experimental subarachnoid hemorrhage in dogs.

Authors:  T Asano; K Sano
Journal:  J Neurosurg       Date:  1977-04       Impact factor: 5.115

9.  Computed tomography in the evaluation of intracranial aneurysms and subarachnoid hemorrhage.

Authors:  G Scotti; R Ethier; D Melançon; K Terbrugge; S Tchang
Journal:  Radiology       Date:  1977-04       Impact factor: 11.105

10.  Transient disappearance of cerebral infarcts on CT scan, the so-called fogging effect.

Authors:  E B Skriver; T S Olsen
Journal:  Neuroradiology       Date:  1981       Impact factor: 2.804

View more
  41 in total

1.  Astrocyte-derived glutathione attenuates hemin-induced apoptosis in cerebral microvascular cells.

Authors:  Sangeetha Sukumari-Ramesh; Melissa D Laird; Nagendra Singh; John R Vender; Cargill H Alleyne; Krishnan M Dhandapani
Journal:  Glia       Date:  2010-11-15       Impact factor: 7.452

2.  Isoflurane attenuates blood-brain barrier disruption in ipsilateral hemisphere after subarachnoid hemorrhage in mice.

Authors:  Orhan Altay; Hidenori Suzuki; Yu Hasegawa; Basak Caner; Paul R Krafft; Mutsumi Fujii; Jiping Tang; John H Zhang
Journal:  Stroke       Date:  2012-07-05       Impact factor: 7.914

3.  Immediate CT findings following embolization of cerebral aneurysms: suggestion of blood-brain barrier or vascular permeability change.

Authors:  Seung Kug Baik; Yong Sun Kim; Hui Jung Lee; Jaechan Park; Gab Chul Kim
Journal:  Neuroradiology       Date:  2007-11-23       Impact factor: 2.804

4.  Interleukin 6-Mediated Endothelial Barrier Disturbances Can Be Attenuated by Blockade of the IL6 Receptor Expressed in Brain Microvascular Endothelial Cells.

Authors:  Kinga G Blecharz-Lang; Josephin Wagner; Alexa Fries; Melina Nieminen-Kelhä; Jörg Rösner; Ulf C Schneider; Peter Vajkoczy
Journal:  Transl Stroke Res       Date:  2018-02-10       Impact factor: 6.829

Review 5.  Binaural blood flow control by astrocytes: listening to synapses and the vasculature.

Authors:  Anusha Mishra
Journal:  J Physiol       Date:  2016-10-14       Impact factor: 5.182

6.  Protective effect 3,4-dihydroxyphenylethanol in subarachnoid hemorrhage provoked oxidative neuropathy.

Authors:  Yu-Wen Zhong; Juan Wu; Hua-Long Hu; Wei-Xin Li; Yong Zhong
Journal:  Exp Ther Med       Date:  2016-07-14       Impact factor: 2.447

7.  Plasticity of cerebrovascular smooth muscle cells after subarachnoid hemorrhage.

Authors:  Lars Edvinsson; Stine Schmidt Larsen; Aida Maddahi; Janne Nielsen
Journal:  Transl Stroke Res       Date:  2014-01-22       Impact factor: 6.829

Review 8.  Delayed neurological deterioration after subarachnoid haemorrhage.

Authors:  R Loch Macdonald
Journal:  Nat Rev Neurol       Date:  2013-12-10       Impact factor: 42.937

9.  Cannabinoid type 2 receptor stimulation attenuates brain edema by reducing cerebral leukocyte infiltration following subarachnoid hemorrhage in rats.

Authors:  Mutsumi Fujii; Prativa Sherchan; Paul R Krafft; William B Rolland; Yoshiteru Soejima; John H Zhang
Journal:  J Neurol Sci       Date:  2014-04-30       Impact factor: 3.181

10.  A Systematic Review of Cognitive Outcomes in Angiographically Negative Subarachnoid Haemorrhage.

Authors:  Tom Burke; Stephanie Hughes; Alan Carr; Mohsen Javadpour; Niall Pender
Journal:  Neuropsychol Rev       Date:  2018-10-23       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.